The cancer supportive care market’s promise of holistic care is overshadowed by an affordability crisis, with many life-enhancing therapies and services priced beyond reach for low-income patients. High costs, driven by R&D investments, patent protections, and limited competition in niche segments, have created disparities: affluent patients access cutting-edge supportive care, while...